Affiliation:
1. Department of Neurology, BG-University Hospital Bergmannsheil, Ruhr-University Bochum, Bochum, Germany
2. Department of Neurology, Klinikum Dortmund, University Witten-Herdecke, Dortmund, Germany
3. Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands
4. Heimer Institute for Muscle Research, BG-University Hospital Bergmannsheil, Bochum, Germany
Abstract
Background: Sporadic inclusion body myositis (sIBM) is the predominant idiopathic inflammatory myopathy (IIM) in older people. Limitations of classical clinical assessments have been discussed as possible explanations for failed clinical trials, underlining the need for more sensitive outcome measures. Quantitative muscle MRI (qMRI) is a promising candidate for evaluating and monitoring sIBM. Objective: Longitudinal assessment of qMRI in sIBM patients. Methods: We evaluated fifteen lower extremity muscles of 12 sIBM patients (5 females, mean age 69.6, BMI 27.8) and 12 healthy age- and gender-matched controls. Seven patients and matched controls underwent a follow-up evaluation after one year. Clinical assessment included testing for muscle strength with Quick Motor Function Measure (QMFM), IBM functional rating scale (IBM-FRS), and gait analysis (6-minute walking distance). 3T-MRI scans of the lower extremities were performed, including a Dixon-based sequence, T2 mapping and Diffusion Tensor Imaging. The qMRI-values fat-fraction (FF), water T2 relaxation time (wT2), fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (λ1), and radial diffusivity (RD) were analysed. Results: Compared to healthy controls, significant differences for all qMRI parameters averaged over all muscles were found in sIBM using a MANOVA (p < 0.001). In low-fat muscles (FF < 10%), a significant increase of wT2 and FA with an accompanying decrease of MD, λ1, and RD was observed (p≤0.020). The highest correlation with clinical assessments was found for wT2 values in thigh muscles (r≤–0.634). Significant changes of FF (+3.0%), wT2 (+0.6 ms), MD (–0.04 10-3mm2/s), λ1 (–0.05 10-3mm2/s), and RD (–0.03 10-3mm2/s) were observed in the longitudinal evaluation of sIBM patients (p≤0.001). FA showed no significant change (p = 0.242). Conclusion: qMRI metrics correlate with clinical findings and can reflect different ongoing pathophysiological mechanisms. While wT2 is an emerging marker of disease activity, the role of diffusion metrics, possibly reflecting changes in fibre size and intracellular deposits, remains subject to further investigations.
Reference62 articles.
1. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study;Dobloug;Eur J Neurol,2015
2. Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis;Lindgren;Ann Neurol,2022
3. 188th ENMC international workshop: Inclusion body myositis, 2-4 December 2011, Naarden, the Netherlands;Rose;Neuromuscul Disord,2013
4. Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges;Mohannak;Int J Gen Med,2019
5. An overview of polymyositis and dermatomyositis;Findlay;Muscle Nerve,2015